153 related articles for article (PubMed ID: 11724785)
1. Dominant-negative suppression of HNF-1 alpha results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide-, but not to high glucose-induced cell death.
Wobser H; Düssmann H; Kögel D; Wang H; Reimertz C; Wollheim CB; Byrne MM; Prehn JH
J Biol Chem; 2002 Feb; 277(8):6413-21. PubMed ID: 11724785
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of protein kinase B/Akt-1 mediates INS-1 insulinoma cell apoptosis induced by dominant-negative suppression of hepatocyte nuclear factor-1alpha function.
Wobser H; Bonner C; Nolan JJ; Byrne MM; Prehn JH
Diabetologia; 2006 Mar; 49(3):519-26. PubMed ID: 16440211
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells.
Yang Q; Yamagata K; Fukui K; Cao Y; Nammo T; Iwahashi H; Wang H; Matsumura I; Hanafusa T; Bucala R; Wollheim CB; Miyagawa J; Matsuzawa Y
Diabetes; 2002 Jun; 51(6):1785-92. PubMed ID: 12031966
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction contributes to impaired insulin secretion in INS-1 cells with dominant-negative mutations of HNF-1alpha and in HNF-1alpha-deficient islets.
Pongratz RL; Kibbey RG; Kirkpatrick CL; Zhao X; Pontoglio M; Yaniv M; Wollheim CB; Shulman GI; Cline GW
J Biol Chem; 2009 Jun; 284(25):16808-16821. PubMed ID: 19376774
[TBL] [Abstract][Full Text] [Related]
5. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells.
Bonner C; Bacon S; Concannon CG; Rizvi SR; Baquié M; Farrelly AM; Kilbride SM; Dussmann H; Ward MW; Boulanger CM; Wollheim CB; Graf R; Byrne MM; Prehn JH
Diabetes; 2010 Nov; 59(11):2799-808. PubMed ID: 20682686
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.
Wang H; Maechler P; Hagenfeldt KA; Wollheim CB
EMBO J; 1998 Nov; 17(22):6701-13. PubMed ID: 9822613
[TBL] [Abstract][Full Text] [Related]
7. Promoter-specific repression of hepatocyte nuclear factor (HNF)-1 beta and HNF-1 alpha transcriptional activity by an HNF-1 beta missense mutant associated with Type 5 maturity-onset diabetes of the young with hepatic and biliary manifestations.
Kitanaka S; Miki Y; Hayashi Y; Igarashi T
J Clin Endocrinol Metab; 2004 Mar; 89(3):1369-78. PubMed ID: 15001636
[TBL] [Abstract][Full Text] [Related]
8. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative.
Yamagata K; Yang Q; Yamamoto K; Iwahashi H; Miyagawa J; Okita K; Yoshiuchi I; Miyazaki J; Noguchi T; Nakajima H; Namba M; Hanafusa T; Matsuzawa Y
Diabetes; 1998 Aug; 47(8):1231-5. PubMed ID: 9703322
[TBL] [Abstract][Full Text] [Related]
9. Human insulin gene is a target gene of hepatocyte nuclear factor-1alpha (HNF-1alpha) and HNF-1beta.
Okita K; Yang Q; Yamagata K; Hangenfeldt KA; Miyagawa J; Kajimoto Y; Nakajima H; Namba M; Wollheim CB; Hanafusa T; Matsuzawa Y
Biochem Biophys Res Commun; 1999 Sep; 263(2):566-9. PubMed ID: 10491332
[TBL] [Abstract][Full Text] [Related]
10. Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction.
Wang H; Antinozzi PA; Hagenfeldt KA; Maechler P; Wollheim CB
EMBO J; 2000 Aug; 19(16):4257-64. PubMed ID: 10944108
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young.
Ellard S
Hum Mutat; 2000 Nov; 16(5):377-85. PubMed ID: 11058894
[TBL] [Abstract][Full Text] [Related]
12. MODY associated with two novel hepatocyte nuclear factor-1alpha loss-of-function mutations (P112L and Q466X).
Bjørkhaug L; Ye H; Horikawa Y; Søvik O; Molven A; Njølstad PR
Biochem Biophys Res Commun; 2000 Dec; 279(3):792-8. PubMed ID: 11162430
[TBL] [Abstract][Full Text] [Related]
13. Experimental models of transcription factor-associated maturity-onset diabetes of the young.
Wang H; Hagenfeldt-Johansson K; Otten LA; Gauthier BR; Herrera PL; Wollheim CB
Diabetes; 2002 Dec; 51 Suppl 3():S333-42. PubMed ID: 12475772
[TBL] [Abstract][Full Text] [Related]
14. Liver and kidney function in Japanese patients with maturity-onset diabetes of the young.
Iwasaki N; Ogata M; Tomonaga O; Kuroki H; Kasahara T; Yano N; Iwamoto Y
Diabetes Care; 1998 Dec; 21(12):2144-8. PubMed ID: 9839108
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians.
Baier LJ; Permana PA; Traurig M; Dobberfuhl A; Wiedrich C; Sutherland J; Thuillez P; Luczy-Bachman G; Hara M; Horikawa Y; Hinokio Y; Hanson RL; Bogardus C
Diabetes Care; 2000 Mar; 23(3):302-4. PubMed ID: 10868855
[TBL] [Abstract][Full Text] [Related]
16. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1 alpha induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice.
Hagenfeldt-Johansson KA; Herrera PL; Wang H; Gjinovci A; Ishihara H; Wollheim CB
Endocrinology; 2001 Dec; 142(12):5311-20. PubMed ID: 11713231
[TBL] [Abstract][Full Text] [Related]
17. Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter.
Suaud L; Hemimou Y; Formstecher P; Laine B
Diabetes; 1999 May; 48(5):1162-7. PubMed ID: 10331424
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway.
Bjørkhaug L; Sagen JV; Thorsby P; Søvik O; Molven A; Njølstad PR
J Clin Endocrinol Metab; 2003 Feb; 88(2):920-31. PubMed ID: 12574234
[TBL] [Abstract][Full Text] [Related]
19. Structure/function studies of hepatocyte nuclear factor-1alpha, a diabetes-associated transcription factor.
Yang Q; Yamagata K; Yamamoto K; Miyagawa J; Takeda J; Iwasaki N; Iwahashi H; Yoshiuchi I; Namba M; Miyazaki J; Hanafusa T; Matsuzawa Y
Biochem Biophys Res Commun; 1999 Dec; 266(1):196-202. PubMed ID: 10581189
[TBL] [Abstract][Full Text] [Related]
20. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
